Hitachi Chemical Diagnostics Mountain View Ca

Lab Reagents

Hitachi Exocomplete Laboratories manufactures the hitachi chemical diagnostics mountain view ca reagents distributed by Genprice. The Hitachi Chemical Diagnostics Mountain View Ca reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact Hitachi Exocomplete. Other Hitachi products are available in stock. Specificity: Hitachi Category: Chemical Group: Diagnostics Mountain

Diagnostics Mountain information

Kinesis Piston Seal Merck Hitachi L Series (Clear)

CHR6401 EACH
EUR 33.06

Gastrointestinal Cancer Antigen (CA 19-9), antigen grade

CA1991-N-10 10 KU
EUR 634.8

Chemical Phosphorylation Reagent I (CPR I)

6001 1 g
EUR 576

Mouse iPSC Chemical Reprogramming Cocktails Kit

K1022-500 Chemical Reprogramming Cocktail+Dual Inhibition (2i) Medium Additive for 500 mL medium
EUR 613.2

Portwest A820 Neoprene Chemical Gauntlet - Small

SAF1444 PK12
EUR 70.22

Portwest A820 Neoprene Chemical Gauntlet - Medium

SAF1446 PK12
EUR 70.22

Portwest A820 Neoprene Chemical Gauntlet - Large

SAF1448 PK12
EUR 70.22

VACU-GUARD 150 CHEMICAL TRAP ACTIVATED

WHA67221001 EACH
EUR 172.14

VACU-GUARD 150 CHEMICAL TRAP DESICCANT

WHA67221002 EACH
EUR 172.14

VACU-GUARD 150 CHEMICAL TRAP MOLECULAR

WHA67221003 EACH
EUR 168.72

AN3 CA

C0026002 One Frozen vial
EUR 651.6

CA 074

A1926-1 1 mg
EUR 177.6
Description: CA-074, a specific cathepsin B inhibitor, also abolished the neurotoxic effects caused by Abeta42-activated BV2 cell [1]. Co-treatment of cultures with the cathepsin B inhibitors CA-074 or Z-FA-FMK suppressed the cytostatic effects of TPA and activation of pro-uPA [2].

CA 074

A1926-10 10 mg
EUR 582
Description: CA-074, a specific cathepsin B inhibitor, also abolished the neurotoxic effects caused by Abeta42-activated BV2 cell [1]. Co-treatment of cultures with the cathepsin B inhibitors CA-074 or Z-FA-FMK suppressed the cytostatic effects of TPA and activation of pro-uPA [2].

CA 074

A1926-25 25 mg
EUR 895.2
Description: CA-074, a specific cathepsin B inhibitor, also abolished the neurotoxic effects caused by Abeta42-activated BV2 cell [1]. Co-treatment of cultures with the cathepsin B inhibitors CA-074 or Z-FA-FMK suppressed the cytostatic effects of TPA and activation of pro-uPA [2].

CA 074

A1926-5 5 mg
EUR 373.2
Description: CA-074, a specific cathepsin B inhibitor, also abolished the neurotoxic effects caused by Abeta42-activated BV2 cell [1]. Co-treatment of cultures with the cathepsin B inhibitors CA-074 or Z-FA-FMK suppressed the cytostatic effects of TPA and activation of pro-uPA [2].

CA 074

A1926-5.1 10 mM (in 1mL DMSO)
EUR 518.4
Description: CA-074, a specific cathepsin B inhibitor, also abolished the neurotoxic effects caused by Abeta42-activated BV2 cell [1]. Co-treatment of cultures with the cathepsin B inhibitors CA-074 or Z-FA-FMK suppressed the cytostatic effects of TPA and activation of pro-uPA [2].

CA 074

A1926-S Evaluation Sample
EUR 97.2
Description: CA-074, a specific cathepsin B inhibitor, also abolished the neurotoxic effects caused by Abeta42-activated BV2 cell [1]. Co-treatment of cultures with the cathepsin B inhibitors CA-074 or Z-FA-FMK suppressed the cytostatic effects of TPA and activation of pro-uPA [2].